Zydalis MD 10 Tablet contains Tadalafil 10 mg, a selective phosphodiesterase type 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction (ED) in adult males. Tadalafil enhances erectile function by increasing blood flow to the penis during sexual stimulation through the inhibition of PDE5, an enzyme responsible for the degradation of cyclic guanosine monophosphate (cGMP). This action facilitates smooth muscle relaxation in the corpus cavernosum, promoting penile erection. Zydalis MD 10 is typically administered orally, with onset of action occurring within 30 to 60 minutes, and effects lasting up to 36 hours, allowing for greater spontaneity in sexual activity. The tablet should be taken as directed by a healthcare professional, usually prior to anticipated sexual activity, and not more than once daily. It is contraindicated in patients using nitrates or nitric oxide donors due to the risk of severe hypotension. Caution is advised in individuals with cardiovascular conditions, hepatic or renal impairment, and those taking alpha-blockers or other antihypertensive agents. Common adverse effects include headache, dyspepsia, back pain, and flushing. Patients experiencing sudden vision loss or prolonged erections should seek immediate medical attention. Zydalis MD 10 Tablet offers an effective therapeutic option for managing erectile dysfunction when used responsibly under medical supervision.